Is There Long-Term Clinical Equipoise Between CABG and PCI for Isolated Left Anterior Descending Artery Disease?
作者信息
Navarese Eliano P, Ruscio Eleonora, Gorog Diana A
机构信息
Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
Faculty of Medicine, University of Alberta, Edmonton, Canada.
出版信息
J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100611. doi: 10.1016/j.jscai.2023.100611. eCollection 2023 Jul-Aug.
Abstract
摘要
相似文献
1
Is There Long-Term Clinical Equipoise Between CABG and PCI for Isolated Left Anterior Descending Artery Disease?对于单纯左前降支病变，冠状动脉旁路移植术（CABG）和经皮冠状动脉介入治疗（PCI）之间是否存在长期临床 equipoise？ （注：equipoise 在医学语境中较难找到完全对应的中文词汇，可理解为一种平衡、权衡等意思，此处保留英文未翻译，以便读者理解原文的专业术语含义。）
J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100611. doi: 10.1016/j.jscai.2023.100611. eCollection 2023 Jul-Aug.
2
Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior descending artery.比较稳定型心绞痛且左前降支近段孤立性病变患者行冠状动脉旁路移植术与第二代药物洗脱支架经皮冠状动脉介入治疗的长期临床结局。
Catheter Cardiovasc Interv. 2021 Sep;98(3):447-457. doi: 10.1002/ccd.29247. Epub 2020 Aug 31.
3
Coronary artery bypass grafting versus percutaneous coronary intervention in single-vessel left anterior descending artery disease: mid-term propensity matching study.单支左前降支动脉疾病中冠状动脉搭桥术与经皮冠状动脉介入治疗的比较：中期倾向匹配研究
Indian J Thorac Cardiovasc Surg. 2024 May;40(3):311-317. doi: 10.1007/s12055-023-01657-7. Epub 2023 Dec 22.
4
Minimally invasive coronary bypass versus percutaneous coronary intervention for isolated complex stenosis of the left anterior descending coronary artery.微创冠状动脉搭桥术与经皮冠状动脉介入治疗孤立性左前降支冠状动脉复杂狭窄的比较
J Thorac Cardiovasc Surg. 2022 May;163(5):1839-1846.e1. doi: 10.1016/j.jtcvs.2020.04.171. Epub 2020 May 29.
5
Long-term Incidence of Myocardial Infarction and Death After CABG and PCI for Isolated Left Anterior Descending Artery Disease: A Meta-analysis of Randomized Controlled Trials.孤立性左前降支病变行冠状动脉旁路移植术和经皮冠状动脉介入治疗后心肌梗死和死亡的长期发生率：一项随机对照试验的荟萃分析
J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100636. doi: 10.1016/j.jscai.2023.100636. eCollection 2023 Jul-Aug.
6
Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.孤立性左前降支近端病变：经皮冠状动脉介入治疗与冠状动脉旁路移植术疗效比较
JACC Cardiovasc Interv. 2008 Oct;1(5):483-91. doi: 10.1016/j.jcin.2008.07.001.
7
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.EXCEL 试验中依维莫司洗脱支架与冠状动脉旁路移植术治疗左主干血运重建效果的长期预测和死亡率比较：SYNTAX 评分 II 的前瞻性验证。
Eur Heart J. 2015 May 21;36(20):1231-41. doi: 10.1093/eurheartj/ehu518. Epub 2015 Jan 12.
8
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
9
Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.比较左主干冠状动脉疾病患者经皮冠状动脉介入治疗与药物洗脱支架置入与冠状动脉旁路移植术的 5 年结局：系统评价和荟萃分析。
Atherosclerosis. 2020 Sep;308:50-56. doi: 10.1016/j.atherosclerosis.2020.06.024. Epub 2020 Jul 4.
10
Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左心室射血分数严重降低患者的长期预后
JAMA Cardiol. 2020 Jun 1;5(6):631-641. doi: 10.1001/jamacardio.2020.0239.
本文引用的文献
1
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.糖尿病合并复杂冠状动脉疾病患者经皮或手术血运重建后 10 年全因死亡。
Eur Heart J. 2021 Dec 28;43(1):56-67. doi: 10.1093/eurheartj/ehab441.
2
When a meta-analysis equals a single large-scale trial with meaningful follow-up.当一项荟萃分析等同于一项具有有意义随访的大规模试验时。
Eur Heart J. 2021 Oct 1;42(37):3884-3885. doi: 10.1093/eurheartj/ehab460.
3
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.择期冠状动脉血运重建术加药物治疗与单纯药物治疗患者的心脏死亡率：系统评价和荟萃分析。
Eur Heart J. 2021 Dec 1;42(45):4638-4651. doi: 10.1093/eurheartj/ehab246.
4
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.经冠状动脉近红外光谱和超声（PROSPECT II）识别易损斑块和患者：一项前瞻性自然史研究。
Lancet. 2021 Mar 13;397(10278):985-995. doi: 10.1016/S0140-6736(21)00249-X.
5
Long-Term Outcomes Following Coronary Revascularizations in Diabetes Mellitus: The Emerging Role of LDL-C Thresholds.糖尿病患者冠状动脉血运重建后的长期预后：低密度脂蛋白胆固醇阈值的新作用
J Am Coll Cardiol. 2020 Nov 10;76(19):2208-2211. doi: 10.1016/j.jacc.2020.09.576.
6
Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.围手术期心肌生物标志物升高对择期经皮冠状动脉介入治疗后死亡率的影响。
JACC Cardiovasc Interv. 2019 Oct 14;12(19):1954-1962. doi: 10.1016/j.jcin.2019.07.014.
7
PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week.经皮冠状动脉介入治疗和冠状动脉旁路移植术治疗稳定性冠状动脉疾病：JACC 本周回顾主题。
J Am Coll Cardiol. 2019 Mar 5;73(8):964-976. doi: 10.1016/j.jacc.2018.11.053.
8
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.降脂治疗后 LDL-C 水平与全因及心血管死亡率的相关性：系统评价和荟萃分析。
JAMA. 2018 Apr 17;319(15):1566-1579. doi: 10.1001/jama.2018.2525.
9
Diabetes with coronary disease--a moving target amid evolving therapies?糖尿病合并冠心病——在不断发展的治疗方法中，这是一个不断变化的目标？
N Engl J Med. 2009 Jun 11;360(24):2570-2. doi: 10.1056/NEJMe0904090. Epub 2009 Jun 7.
Zotero 插件